Tag Archives: BioLife Solutions

The Exec VP & Chief Scientific Off of BioLife Solutions (NASDAQ: BLFS) is Selling Shares

Yesterday, the Exec VP & Chief Scientific Off of BioLife Solutions (BLFS – Research Report), Aby Mathew, sold shares of BLFS for $105.6K. In addition to Aby Mathew, 6 other BLFS executives reported Sell trades in the last month. See

A Director at BioLife Solutions is Exercising Options

Yesterday it was reported that a Director at BioLife Solutions (BLFS – Research Report), Joseph Schick, exercised options to sell 6,250 BLFS shares at $1.90 a share, for a total transaction value of $207K. In addition to Joseph Schick, 13

The CMO of BioLife Solutions is Exercising Options

Yesterday it was reported that the CMO of BioLife Solutions (BLFS – Research Report), Todd Berard, exercised options to sell 11,000 BLFS shares at $2.06 a share, for a total transaction value of $355.6K. In addition to Todd Berard, 13

The CMO of BioLife Solutions (NASDAQ: BLFS) is Selling Shares

On October 1, the CMO of BioLife Solutions (BLFS – Research Report), Todd Berard, sold shares of BLFS for $23.13K. In addition to Todd Berard, 4 other BLFS executives reported Sell trades in the last month. See today’s analyst top

B.Riley FBR Believes BioLife Solutions (NASDAQ: BLFS) Won’t Stop Here

B.Riley FBR analyst Marc Wiesenberger reiterated a Buy rating on BioLife Solutions (BLFS – Research Report) today and set a price target of $25.50. The company’s shares closed last Thursday at $20.67, close to its 52-week high of $22.25. According

Northland Securities Keeps a Buy Rating on BioLife Solutions (BLFS)

In a report released today, Carl Byrnes from Northland Securities maintained a Buy rating on BioLife Solutions (BLFS – Research Report), with a price target of $28.00. The company’s shares closed last Thursday at $20.67, close to its 52-week high